{"gene":"PCLO","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2002,"finding":"PCLO encodes Piccolo, a presynaptic cytoskeletal protein containing distinct homology domains, and comparison with Bassoon (a structurally related active zone protein) shows only subsets of domains are shared, indicating Piccolo and Bassoon perform related but distinct functions at presynaptic active zones as sites of neurotransmitter release.","method":"cDNA cloning, amino acid sequence comparison across human, mouse, rat, and chicken; gene structure characterization (25 coding exons over 380 kb)","journal":"International journal of developmental neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — sequence/domain analysis of a single lab establishing domain architecture; no functional mutagenesis in this paper","pmids":["12175852"],"is_preprint":false},{"year":2013,"finding":"The intronic SNP rs13438494 (C allele) in PCLO intron 24 reduces splicing efficiency of the PCLO minigene, acting by creating or disrupting splicing regulatory motifs (enhancer/silencer binding sites).","method":"Minigene splicing assay with A and C alleles; bioinformatics prediction of splicing regulatory sequences (Human Splice Finder)","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional minigene assay in single lab with bioinformatics support, but no protein-level validation","pmids":["24167553"],"is_preprint":false},{"year":2015,"finding":"The PCLO p.Ser4814Ala (rs2522833) variant, located near a calcium-sensing domain of Piccolo, increases synaptic Piccolo protein levels and produces ~30% increased excitatory synaptic transmission in cultured neurons; however, calcium-dependent phospholipid binding, synapse formation in vitro, and synaptic accumulation of synaptic vesicles were unaltered by this variant.","method":"Mouse knock-in model (Pclo-SA/SA), immunostaining for synaptic Piccolo levels, electrophysiology of cultured neurons, calcium-dependent phospholipid binding assay, in vitro synapse formation assay","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (knock-in model, electrophysiology, biochemical binding assay, morphological analysis) in single lab","pmids":["26045179"],"is_preprint":false},{"year":2015,"finding":"A homozygous nonsense mutation in PCLO, predicted to eliminate the PDZ and C2 domains in the C-terminus of the protein, underlies pontocerebellar hypoplasia type 3 (PCH3), establishing that loss of PCLO function is causative for this autosomal recessive neurodegenerative disorder.","method":"Genome-wide SNP genotyping, linkage analysis, whole-exome sequencing, Sanger sequencing, human fetal brain RNA sequencing","journal":"Neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic loss-of-function established by sequencing and segregation analysis in a single pedigree; no in vitro functional rescue","pmids":["25832664"],"is_preprint":false},{"year":2021,"finding":"Rare missense mutations in PCLO (Ser1535Leu and His5142Arg) co-segregate with bipolar disorder and schizophrenia respectively in affected families, implicating PCLO's role in regulating neurotransmission at the presynaptic cytomatrix in these disorders.","method":"Whole-genome sequencing, family co-segregation analysis, in silico pathogenicity prediction","journal":"Journal of personalized medicine","confidence":"Low","confidence_rationale":"Tier 4 / Weak — genetic co-segregation plus in silico prediction only; no functional/biochemical validation of these specific variants","pmids":["34834409"],"is_preprint":false},{"year":2025,"finding":"Piccolo loss of function (PCLO knockout via CRISPR) reduces expression of CtBP1 and BSN (Bassoon), indicating Piccolo regulates expression of other presynaptic cytomatrix genes.","method":"CRISPR-generated PCLO knockout cell model, real-time PCR for CtBP1 and BSN expression","journal":"Galen medical journal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method (qPCR in cell model), no protein-level or mechanistic follow-up","pmids":["42038819"],"is_preprint":false},{"year":2025,"finding":"An astrocyte-specific Piccolo isoform localizes partially at the Golgi; loss of Piccolo (Pclo gene trap rat model) causes fragmented Golgi in astrocytes, impaired secretion of extracellular matrix components Brevican and Tenascin-R, reduced synapse density in co-cultured neurons, and altered intrinsic neuronal network activity (increased mEPSC frequency); these synaptic deficits were rescued by conditioned medium from wild-type astrocytes.","method":"Pclo gene-trap rat model; RNA-seq; immunohistochemistry/immunocytochemistry for Piccolo isoform, Brevican, Tenascin-R, and GM130 (Golgi marker); neuron-astrocyte co-culture (Banker setup); electrophysiology (RRP, mEPSC, mIPSC); astrocyte-conditioned media rescue experiment","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (imaging, electrophysiology, conditioned media rescue) in single lab; preprint not yet peer-reviewed","pmids":[],"is_preprint":true},{"year":2025,"finding":"Anti-PCLO autoantibodies and PCLO-reactive T-lymphocytes are detected in ARA-positive sarcoid uveitis patients, identifying PCLO as an autoimmune antigenic target in the retina.","method":"Indirect immunofluorescence for anti-retinal antibodies; HuScan linear epitope mapping; bead-based anti-PCLO antibody assay; ELISpot for PCLO-reactive T-lymphocytes; TCR/BCR repertoire next-generation sequencing","journal":"Journal of autoimmunity","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple orthogonal immunological methods (bead assay, ELISpot, repertoire sequencing) in single study identifying PCLO as an autoimmune target","pmids":["39892202"],"is_preprint":false}],"current_model":"Piccolo (PCLO) is a large presynaptic cytoskeletal scaffolding protein of the active zone that, through its C-terminal PDZ and C2/calcium-sensing domains, regulates synaptic vesicle accumulation, excitatory synaptic transmission, and presynaptic protein levels (including Bassoon and CtBP1); an astrocyte-specific isoform additionally localizes to the Golgi and controls secretion of extracellular matrix components (Brevican, Tenascin-R) required for synapse formation, with loss of PCLO function causing fragmented Golgi, impaired ECM secretion, and reduced synapse density — and in humans, homozygous loss-of-function mutations underlie the autosomal recessive neurodegenerative disorder pontocerebellar hypoplasia type 3."},"narrative":{"mechanistic_narrative":"PCLO encodes Piccolo, a large presynaptic cytoskeletal scaffolding protein of the active zone whose distinct homology domains overlap only partially with the related active zone protein Bassoon, indicating related but non-redundant functions at sites of neurotransmitter release [PMID:12175852]. Piccolo regulates excitatory presynaptic function through a C-terminal region that includes calcium-sensing, PDZ, and C2 domains: a knock-in variant near the calcium-sensing domain raises synaptic Piccolo levels and increases excitatory synaptic transmission by ~30% without altering calcium-dependent phospholipid binding, synaptic vesicle accumulation, or in vitro synapse formation [PMID:26045179], and Piccolo loss reduces expression of the presynaptic cytomatrix partners CtBP1 and Bassoon [PMID:42038819]. An astrocyte-specific Piccolo isoform localizes partly to the Golgi, where its loss fragments the Golgi, impairs secretion of the extracellular matrix components Brevican and Tenascin-R, and reduces synapse density in co-cultured neurons—a deficit rescued by wild-type astrocyte-conditioned medium—revealing a non-neuronal, secretory role in supporting synaptogenesis. A homozygous nonsense mutation eliminating the C-terminal PDZ and C2 domains is causative for the autosomal recessive neurodegenerative disorder pontocerebellar hypoplasia type 3 [PMID:25832664].","teleology":[{"year":2002,"claim":"Established the molecular identity of Piccolo as a presynaptic active zone scaffold and resolved its domain architecture relative to Bassoon, defining whether the two proteins are redundant.","evidence":"cDNA cloning and cross-species sequence/domain comparison with gene structure characterization","pmids":["12175852"],"confidence":"Medium","gaps":["No functional mutagenesis to assign roles to specific domains","Domain homology inferred from sequence, not from structural or biochemical assay","Distinct-versus-shared functions with Bassoon not tested experimentally"]},{"year":2013,"claim":"Tested how a non-coding PCLO variant could alter gene output, showing an intronic SNP modulates splicing efficiency rather than protein coding sequence.","evidence":"Minigene splicing assay comparing alleles with bioinformatic splice-site prediction","pmids":["24167553"],"confidence":"Medium","gaps":["No protein-level validation of altered isoform abundance","Effect shown in minigene, not endogenous context","Functional consequence for neurons not addressed"]},{"year":2015,"claim":"Linked a specific Piccolo variant near the calcium-sensing domain to a quantitative gain in excitatory transmission, distinguishing protein-level effects from vesicle/synapse-formation effects.","evidence":"Pclo-SA/SA knock-in mouse with immunostaining, electrophysiology, phospholipid-binding and synapse-formation assays","pmids":["26045179"],"confidence":"High","gaps":["Mechanism connecting increased Piccolo levels to increased transmission unresolved","Calcium-dependent phospholipid binding unchanged, leaving domain function unexplained","In vivo behavioral or circuit-level consequences not assessed"]},{"year":2015,"claim":"Demonstrated that complete loss of Piccolo C-terminal function causes human neurodegenerative disease, establishing PCLO as causative for pontocerebellar hypoplasia type 3.","evidence":"Linkage, whole-exome and Sanger sequencing with fetal brain RNA-seq in an affected pedigree","pmids":["25832664"],"confidence":"Medium","gaps":["No in vitro or in vivo functional rescue of the mutation","Single pedigree","Cellular pathway from PCLO loss to cerebellar/pontine degeneration not defined"]},{"year":2021,"claim":"Probed whether rare PCLO coding variants contribute to psychiatric disease, finding co-segregation of missense mutations with bipolar disorder and schizophrenia.","evidence":"Whole-genome sequencing with family co-segregation and in silico pathogenicity prediction","pmids":["34834409"],"confidence":"Low","gaps":["No functional or biochemical validation of the specific variants","Co-segregation in limited families with in silico support only","Causal mechanism in neurotransmission untested"]},{"year":2025,"claim":"Addressed whether Piccolo regulates other presynaptic cytomatrix components, showing its loss reduces CtBP1 and Bassoon expression.","evidence":"CRISPR PCLO-knockout cell model with qPCR for CtBP1 and BSN","pmids":["42038819"],"confidence":"Low","gaps":["Single method (qPCR) without protein-level confirmation","Mechanism of transcriptional/expression regulation unknown","Not validated in neurons or in vivo"]},{"year":2025,"claim":"Revealed a non-neuronal role for an astrocyte-specific Piccolo isoform in Golgi-dependent ECM secretion required for synaptogenesis, broadening Piccolo function beyond the presynapse.","evidence":"Pclo gene-trap rat with RNA-seq, Golgi/ECM imaging, neuron-astrocyte co-culture electrophysiology, and conditioned-media rescue (preprint)","pmids":[],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Molecular link between Piccolo and Golgi integrity unresolved","Identity of secreted factor(s) mediating rescue beyond Brevican/Tenascin-R not fully defined"]},{"year":2025,"claim":"Identified PCLO as an autoimmune antigenic target in the retina, indicating disease relevance beyond its structural synaptic role.","evidence":"Anti-retinal immunofluorescence, epitope mapping, bead assay, ELISpot, and TCR/BCR repertoire sequencing in sarcoid uveitis patients","pmids":["39892202"],"confidence":"Medium","gaps":["Causal role of anti-PCLO autoimmunity in disease not established","Mechanism of PCLO exposure to immune surveillance unknown","Relationship to PCLO synaptic function unclear"]},{"year":null,"claim":"How Piccolo's calcium-sensing and C-terminal PDZ/C2 domains mechanistically couple synaptic vesicle dynamics, presynaptic protein homeostasis, and (in astrocytes) Golgi-dependent ECM secretion into a unified molecular pathway remains unresolved.","evidence":"No single study integrates the presynaptic scaffolding and astrocytic secretory roles mechanistically","pmids":[],"confidence":"Low","gaps":["No structural model of the functional domains in complex with partners","Mechanism linking PCLO loss to pontocerebellar degeneration undefined","Domain-level dissection of neuronal versus astrocytic functions lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,2]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[2]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6]}],"complexes":["presynaptic active zone cytomatrix"],"partners":["BSN","CTBP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y6V0","full_name":"Protein piccolo","aliases":["Aczonin"],"length_aa":5142,"mass_kda":560.7,"function":"Scaffold protein of the presynaptic cytomatrix at the active zone (CAZ) which is the place in the synapse where neurotransmitter is released (By similarity). After synthesis, participates in the formation of Golgi-derived membranous organelles termed Piccolo-Bassoon transport vesicles (PTVs) that are transported along axons to sites of nascent synaptic contacts (By similarity). At the presynaptic active zone, regulates the spatial organization of synaptic vesicle cluster, the protein complexes that execute membrane fusion and compensatory endocytosis (By similarity). Organizes as well the readily releasable pool of synaptic vesicles and safeguards a fraction of them to be not immediately available for action potential-induced release (By similarity). Also functions in processes other than assembly such as the regulation of specific presynaptic protein ubiquitination by interacting with SIAH1 or the regulation of presynaptic autophagy (By similarity). Also mediates synapse to nucleus communication leading to reconfiguration of gene expression by associating with the transcriptional corepressor CTBP1 and by subsequently reducing the size of its pool available for nuclear import (By similarity)","subcellular_location":"Presynaptic active zone","url":"https://www.uniprot.org/uniprotkb/Q9Y6V0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PCLO","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PCLO","total_profiled":1310},"omim":[{"mim_id":"617250","title":"ELKS/RAB6-INTERACTING/CAST FAMILY, MEMBER 2; ERC2","url":"https://www.omim.org/entry/617250"},{"mim_id":"609894","title":"UNC13 HOMOLOG A; UNC13A","url":"https://www.omim.org/entry/609894"},{"mim_id":"608027","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3","url":"https://www.omim.org/entry/608027"},{"mim_id":"607596","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A","url":"https://www.omim.org/entry/607596"},{"mim_id":"606629","title":"PROTEIN REGULATING SYNAPTIC MEMBRANE EXOCYTOSIS 1; RIMS1","url":"https://www.omim.org/entry/606629"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Nuclear speckles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":21.2},{"tissue":"retina","ntpm":20.1}],"url":"https://www.proteinatlas.org/search/PCLO"},"hgnc":{"alias_symbol":["KIAA0559","DKFZp779G1236","ACZ"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y6V0","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6V0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6V0-3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6V0-3-F1-predicted_aligned_error_v6.png","plddt_mean":66.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PCLO","jax_strain_url":"https://www.jax.org/strain/search?query=PCLO"},"sequence":{"accession":"Q9Y6V0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y6V0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y6V0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6V0"}},"corpus_meta":[{"pmid":"24167553","id":"PMC_24167553","title":"Functional analysis of deep intronic SNP rs13438494 in intron 24 of PCLO gene.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24167553","citation_count":51,"is_preprint":false},{"pmid":"25832664","id":"PMC_25832664","title":"Loss of PCLO function underlies pontocerebellar hypoplasia type III.","date":"2015","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25832664","citation_count":48,"is_preprint":false},{"pmid":"19942622","id":"PMC_19942622","title":"The PCLO gene and depressive disorders: replication in a population-based study.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19942622","citation_count":38,"is_preprint":false},{"pmid":"12175852","id":"PMC_12175852","title":"Gene structure and genetic localization of the PCLO gene encoding the presynaptic active zone protein Piccolo.","date":"2002","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12175852","citation_count":32,"is_preprint":false},{"pmid":"28540843","id":"PMC_28540843","title":"Genome-Wide Significance for PCLO as a Gene for Major Depressive Disorder.","date":"2017","source":"Twin research and human genetics : the official journal of the International Society for Twin Studies","url":"https://pubmed.ncbi.nlm.nih.gov/28540843","citation_count":22,"is_preprint":false},{"pmid":"34834409","id":"PMC_34834409","title":"Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes BSN and PCLO in Schizophrenia and Bipolar Disorder.","date":"2021","source":"Journal of personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34834409","citation_count":21,"is_preprint":false},{"pmid":"22386049","id":"PMC_22386049","title":"PCLO gene: its role in vulnerability to major depressive disorder.","date":"2012","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/22386049","citation_count":19,"is_preprint":false},{"pmid":"28556829","id":"PMC_28556829","title":"PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorder.","date":"2017","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28556829","citation_count":17,"is_preprint":false},{"pmid":"18647954","id":"PMC_18647954","title":"PCLO variants are nominally associated with early-onset type 2 diabetes and insulin resistance in Pima Indians.","date":"2008","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/18647954","citation_count":16,"is_preprint":false},{"pmid":"20701824","id":"PMC_20701824","title":"PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder.","date":"2010","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20701824","citation_count":12,"is_preprint":false},{"pmid":"22832399","id":"PMC_22832399","title":"PCLO rs2522833 impacts HPA system activity in healthy young adults.","date":"2011","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22832399","citation_count":10,"is_preprint":false},{"pmid":"26045179","id":"PMC_26045179","title":"Functional characterization of the PCLO p.Ser4814Ala variant associated with major depressive disorder reveals cellular but not behavioral differences.","date":"2015","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26045179","citation_count":9,"is_preprint":false},{"pmid":"35328053","id":"PMC_35328053","title":"Characterization of PCLO Gene in Amazonian Native American Populations.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35328053","citation_count":6,"is_preprint":false},{"pmid":"37598873","id":"PMC_37598873","title":"Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle.","date":"2023","source":"International journal of pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/37598873","citation_count":5,"is_preprint":false},{"pmid":"37935138","id":"PMC_37935138","title":"Exploration of the Tumour Biological Significance of PCLO in Gastric Cancer: Results from a Large Central European Cohort.","date":"2023","source":"Pathobiology : journal of immunopathology, molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/37935138","citation_count":5,"is_preprint":false},{"pmid":"23862039","id":"PMC_23862039","title":"Implications of a Chr7q21.11 Microdeletion and the Role of the PCLO Gene in Developmental Delay.","date":"2013","source":"Sultan Qaboos University medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/23862039","citation_count":3,"is_preprint":false},{"pmid":"40699825","id":"PMC_40699825","title":"PCLO Is Associated with Tumor Mutational Burden and Immunity in Patients with Oral Squamous Cell Carcinoma.","date":"2025","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/40699825","citation_count":1,"is_preprint":false},{"pmid":"25379724","id":"PMC_25379724","title":"No evidence for the association between a polymorphism in the PCLO depression candidate gene with memory bias in remitted depressed patients and healthy individuals.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25379724","citation_count":1,"is_preprint":false},{"pmid":"40661989","id":"PMC_40661989","title":"Pontocerebellar Hypoplasia Type 3 With Two Novel PCLO Gene Mutations: A Case Report.","date":"2025","source":"Case reports in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/40661989","citation_count":1,"is_preprint":false},{"pmid":"39892202","id":"PMC_39892202","title":"Anti-retinal immune response in sarcoid uveitis: A potential role for PCLO as an antigenic target.","date":"2025","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/39892202","citation_count":0,"is_preprint":false},{"pmid":"42038819","id":"PMC_42038819","title":"Novel Insights into Pontocerebellar Hypoplasia Type 3: Discovery of a New Disease-causing PCLO Variant and Development of a CRISPR-generated Cell Model : Novel Insights into Pontocerebellar Hypoplasia Type 3.","date":"2025","source":"Galen medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/42038819","citation_count":0,"is_preprint":false},{"pmid":"11550907","id":"PMC_11550907","title":"Genetic and molecular characterization of a variegating hsp70-acZ fusion gene in the euchromatic 31 B region of Drosophila melanogaster.","date":"2001","source":"Genome","url":"https://pubmed.ncbi.nlm.nih.gov/11550907","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.01.21.634055","title":"Modeling Synaptic Maturation from Growth Cone to Synapse in Human Organoids","date":"2025-01-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.21.634055","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.03.662734","title":"Piccolo Regulates Secretion of the Extracellular Matrix Components Brevican and Tenascin R from Astrocytes to Drive Synapse Formation: Implications for Pontocerebellar Hypoplasia Type 3 (PCH3)","date":"2025-07-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.03.662734","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.18.25329418","title":"Imputation of fluid intelligence scores reduces ascertainment bias and increases power for analyses of common and rare variants","date":"2025-06-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.18.25329418","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.09.24315081","title":"A novel model to quantify blood transit time in cerebral arteries using ASL-based 4D magnetic resonance angiography with example clinical application in moyamoya disease","date":"2024-10-11","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.09.24315081","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14699,"output_tokens":2101,"usd":0.037806,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9093,"output_tokens":3063,"usd":0.06102,"stage2_stop_reason":"end_turn"},"total_usd":0.098826,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"PCLO encodes Piccolo, a presynaptic cytoskeletal protein containing distinct homology domains, and comparison with Bassoon (a structurally related active zone protein) shows only subsets of domains are shared, indicating Piccolo and Bassoon perform related but distinct functions at presynaptic active zones as sites of neurotransmitter release.\",\n      \"method\": \"cDNA cloning, amino acid sequence comparison across human, mouse, rat, and chicken; gene structure characterization (25 coding exons over 380 kb)\",\n      \"journal\": \"International journal of developmental neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — sequence/domain analysis of a single lab establishing domain architecture; no functional mutagenesis in this paper\",\n      \"pmids\": [\"12175852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The intronic SNP rs13438494 (C allele) in PCLO intron 24 reduces splicing efficiency of the PCLO minigene, acting by creating or disrupting splicing regulatory motifs (enhancer/silencer binding sites).\",\n      \"method\": \"Minigene splicing assay with A and C alleles; bioinformatics prediction of splicing regulatory sequences (Human Splice Finder)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional minigene assay in single lab with bioinformatics support, but no protein-level validation\",\n      \"pmids\": [\"24167553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The PCLO p.Ser4814Ala (rs2522833) variant, located near a calcium-sensing domain of Piccolo, increases synaptic Piccolo protein levels and produces ~30% increased excitatory synaptic transmission in cultured neurons; however, calcium-dependent phospholipid binding, synapse formation in vitro, and synaptic accumulation of synaptic vesicles were unaltered by this variant.\",\n      \"method\": \"Mouse knock-in model (Pclo-SA/SA), immunostaining for synaptic Piccolo levels, electrophysiology of cultured neurons, calcium-dependent phospholipid binding assay, in vitro synapse formation assay\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (knock-in model, electrophysiology, biochemical binding assay, morphological analysis) in single lab\",\n      \"pmids\": [\"26045179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A homozygous nonsense mutation in PCLO, predicted to eliminate the PDZ and C2 domains in the C-terminus of the protein, underlies pontocerebellar hypoplasia type 3 (PCH3), establishing that loss of PCLO function is causative for this autosomal recessive neurodegenerative disorder.\",\n      \"method\": \"Genome-wide SNP genotyping, linkage analysis, whole-exome sequencing, Sanger sequencing, human fetal brain RNA sequencing\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic loss-of-function established by sequencing and segregation analysis in a single pedigree; no in vitro functional rescue\",\n      \"pmids\": [\"25832664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Rare missense mutations in PCLO (Ser1535Leu and His5142Arg) co-segregate with bipolar disorder and schizophrenia respectively in affected families, implicating PCLO's role in regulating neurotransmission at the presynaptic cytomatrix in these disorders.\",\n      \"method\": \"Whole-genome sequencing, family co-segregation analysis, in silico pathogenicity prediction\",\n      \"journal\": \"Journal of personalized medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — genetic co-segregation plus in silico prediction only; no functional/biochemical validation of these specific variants\",\n      \"pmids\": [\"34834409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Piccolo loss of function (PCLO knockout via CRISPR) reduces expression of CtBP1 and BSN (Bassoon), indicating Piccolo regulates expression of other presynaptic cytomatrix genes.\",\n      \"method\": \"CRISPR-generated PCLO knockout cell model, real-time PCR for CtBP1 and BSN expression\",\n      \"journal\": \"Galen medical journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method (qPCR in cell model), no protein-level or mechanistic follow-up\",\n      \"pmids\": [\"42038819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"An astrocyte-specific Piccolo isoform localizes partially at the Golgi; loss of Piccolo (Pclo gene trap rat model) causes fragmented Golgi in astrocytes, impaired secretion of extracellular matrix components Brevican and Tenascin-R, reduced synapse density in co-cultured neurons, and altered intrinsic neuronal network activity (increased mEPSC frequency); these synaptic deficits were rescued by conditioned medium from wild-type astrocytes.\",\n      \"method\": \"Pclo gene-trap rat model; RNA-seq; immunohistochemistry/immunocytochemistry for Piccolo isoform, Brevican, Tenascin-R, and GM130 (Golgi marker); neuron-astrocyte co-culture (Banker setup); electrophysiology (RRP, mEPSC, mIPSC); astrocyte-conditioned media rescue experiment\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (imaging, electrophysiology, conditioned media rescue) in single lab; preprint not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Anti-PCLO autoantibodies and PCLO-reactive T-lymphocytes are detected in ARA-positive sarcoid uveitis patients, identifying PCLO as an autoimmune antigenic target in the retina.\",\n      \"method\": \"Indirect immunofluorescence for anti-retinal antibodies; HuScan linear epitope mapping; bead-based anti-PCLO antibody assay; ELISpot for PCLO-reactive T-lymphocytes; TCR/BCR repertoire next-generation sequencing\",\n      \"journal\": \"Journal of autoimmunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple orthogonal immunological methods (bead assay, ELISpot, repertoire sequencing) in single study identifying PCLO as an autoimmune target\",\n      \"pmids\": [\"39892202\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Piccolo (PCLO) is a large presynaptic cytoskeletal scaffolding protein of the active zone that, through its C-terminal PDZ and C2/calcium-sensing domains, regulates synaptic vesicle accumulation, excitatory synaptic transmission, and presynaptic protein levels (including Bassoon and CtBP1); an astrocyte-specific isoform additionally localizes to the Golgi and controls secretion of extracellular matrix components (Brevican, Tenascin-R) required for synapse formation, with loss of PCLO function causing fragmented Golgi, impaired ECM secretion, and reduced synapse density — and in humans, homozygous loss-of-function mutations underlie the autosomal recessive neurodegenerative disorder pontocerebellar hypoplasia type 3.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PCLO encodes Piccolo, a large presynaptic cytoskeletal scaffolding protein of the active zone whose distinct homology domains overlap only partially with the related active zone protein Bassoon, indicating related but non-redundant functions at sites of neurotransmitter release [#0]. Piccolo regulates excitatory presynaptic function through a C-terminal region that includes calcium-sensing, PDZ, and C2 domains: a knock-in variant near the calcium-sensing domain raises synaptic Piccolo levels and increases excitatory synaptic transmission by ~30% without altering calcium-dependent phospholipid binding, synaptic vesicle accumulation, or in vitro synapse formation [#2], and Piccolo loss reduces expression of the presynaptic cytomatrix partners CtBP1 and Bassoon [#5]. An astrocyte-specific Piccolo isoform localizes partly to the Golgi, where its loss fragments the Golgi, impairs secretion of the extracellular matrix components Brevican and Tenascin-R, and reduces synapse density in co-cultured neurons—a deficit rescued by wild-type astrocyte-conditioned medium—revealing a non-neuronal, secretory role in supporting synaptogenesis [#6]. A homozygous nonsense mutation eliminating the C-terminal PDZ and C2 domains is causative for the autosomal recessive neurodegenerative disorder pontocerebellar hypoplasia type 3 [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established the molecular identity of Piccolo as a presynaptic active zone scaffold and resolved its domain architecture relative to Bassoon, defining whether the two proteins are redundant.\",\n      \"evidence\": \"cDNA cloning and cross-species sequence/domain comparison with gene structure characterization\",\n      \"pmids\": [\"12175852\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No functional mutagenesis to assign roles to specific domains\",\n        \"Domain homology inferred from sequence, not from structural or biochemical assay\",\n        \"Distinct-versus-shared functions with Bassoon not tested experimentally\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Tested how a non-coding PCLO variant could alter gene output, showing an intronic SNP modulates splicing efficiency rather than protein coding sequence.\",\n      \"evidence\": \"Minigene splicing assay comparing alleles with bioinformatic splice-site prediction\",\n      \"pmids\": [\"24167553\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No protein-level validation of altered isoform abundance\",\n        \"Effect shown in minigene, not endogenous context\",\n        \"Functional consequence for neurons not addressed\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Linked a specific Piccolo variant near the calcium-sensing domain to a quantitative gain in excitatory transmission, distinguishing protein-level effects from vesicle/synapse-formation effects.\",\n      \"evidence\": \"Pclo-SA/SA knock-in mouse with immunostaining, electrophysiology, phospholipid-binding and synapse-formation assays\",\n      \"pmids\": [\"26045179\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism connecting increased Piccolo levels to increased transmission unresolved\",\n        \"Calcium-dependent phospholipid binding unchanged, leaving domain function unexplained\",\n        \"In vivo behavioral or circuit-level consequences not assessed\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated that complete loss of Piccolo C-terminal function causes human neurodegenerative disease, establishing PCLO as causative for pontocerebellar hypoplasia type 3.\",\n      \"evidence\": \"Linkage, whole-exome and Sanger sequencing with fetal brain RNA-seq in an affected pedigree\",\n      \"pmids\": [\"25832664\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No in vitro or in vivo functional rescue of the mutation\",\n        \"Single pedigree\",\n        \"Cellular pathway from PCLO loss to cerebellar/pontine degeneration not defined\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Probed whether rare PCLO coding variants contribute to psychiatric disease, finding co-segregation of missense mutations with bipolar disorder and schizophrenia.\",\n      \"evidence\": \"Whole-genome sequencing with family co-segregation and in silico pathogenicity prediction\",\n      \"pmids\": [\"34834409\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No functional or biochemical validation of the specific variants\",\n        \"Co-segregation in limited families with in silico support only\",\n        \"Causal mechanism in neurotransmission untested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Addressed whether Piccolo regulates other presynaptic cytomatrix components, showing its loss reduces CtBP1 and Bassoon expression.\",\n      \"evidence\": \"CRISPR PCLO-knockout cell model with qPCR for CtBP1 and BSN\",\n      \"pmids\": [\"42038819\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Single method (qPCR) without protein-level confirmation\",\n        \"Mechanism of transcriptional/expression regulation unknown\",\n        \"Not validated in neurons or in vivo\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Revealed a non-neuronal role for an astrocyte-specific Piccolo isoform in Golgi-dependent ECM secretion required for synaptogenesis, broadening Piccolo function beyond the presynapse.\",\n      \"evidence\": \"Pclo gene-trap rat with RNA-seq, Golgi/ECM imaging, neuron-astrocyte co-culture electrophysiology, and conditioned-media rescue (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Preprint not yet peer-reviewed\",\n        \"Molecular link between Piccolo and Golgi integrity unresolved\",\n        \"Identity of secreted factor(s) mediating rescue beyond Brevican/Tenascin-R not fully defined\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified PCLO as an autoimmune antigenic target in the retina, indicating disease relevance beyond its structural synaptic role.\",\n      \"evidence\": \"Anti-retinal immunofluorescence, epitope mapping, bead assay, ELISpot, and TCR/BCR repertoire sequencing in sarcoid uveitis patients\",\n      \"pmids\": [\"39892202\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Causal role of anti-PCLO autoimmunity in disease not established\",\n        \"Mechanism of PCLO exposure to immune surveillance unknown\",\n        \"Relationship to PCLO synaptic function unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How Piccolo's calcium-sensing and C-terminal PDZ/C2 domains mechanistically couple synaptic vesicle dynamics, presynaptic protein homeostasis, and (in astrocytes) Golgi-dependent ECM secretion into a unified molecular pathway remains unresolved.\",\n      \"evidence\": \"No single study integrates the presynaptic scaffolding and astrocytic secretory roles mechanistically\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of the functional domains in complex with partners\",\n        \"Mechanism linking PCLO loss to pontocerebellar degeneration undefined\",\n        \"Domain-level dissection of neuronal versus astrocytic functions lacking\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [\"presynaptic active zone cytomatrix\"],\n    \"partners\": [\"BSN\", \"CTBP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":3,"faith_total":3,"faith_pct":100.0}}